Search - tctmd.com

Displaying 261 - 280 of 300

Sort: Relevancy | Date

News Conference News

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

November 17, 2011

News Conference News

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

November 16, 2011

News Conference News

RAPID GENE: Validation of Point-of-Care Genetic Testing

November 09, 2011

News Industry News

Low CV Event Rate Prompts Closure of Prasugrel Trial

November 09, 2011

News Industry News

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

November 08, 2011

News Industry News

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

November 08, 2011

News Industry News

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

November 08, 2011

News Industry News

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

November 08, 2011

News Industry News

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

November 08, 2011

News Industry News

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

November 08, 2011

News Conference News

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

November 06, 2011

News Daily News

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

October 26, 2011

News Daily News

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Jason Kahn

October 24, 2011

News Daily News

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

September 21, 2011

News Daily News

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

L.A. McKeown

September 20, 2011

News Conference News

ESC Congress 2011: Drugs, Devices Work Together

Caitlin E. Cox

September 06, 2011

News Conference News

Halting Clopidogrel in First Year Following Acute MI Hazardous

September 01, 2011

News Conference News

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

August 30, 2011

News Daily News

Women Have Less Neointimal Hyperplasia Than Men With ZES

Leah Lawrence

July 29, 2011

News Daily News

Poor Association Between Stent Thrombosis, Platelet Function Tests

L.A. McKeown

July 26, 2011

Advertisement

Prasugrel Bests Double Clopidogrel Dose for STEMI Patients with High Residual Platelet Reactivity

Higher Dosing Improves Clopidogrel Response in Carriers of Variant Genes

RAPID GENE: Validation of Point-of-Care Genetic Testing

Low CV Event Rate Prompts Closure of Prasugrel Trial

Tailored therapy for anti-platelet drugs using a novel point-of-care genetic test provides improved response to medications compared to current standard of care

Scripps Health and The Medicines Company Announce Late Breaking BRIDGE Trial Results Presented at TCT

Patients with ACS and/or diabetes who show poor response to dual antiplatelet therapy

First clinical trial of point-of-care DNA testing in medicine enables cardiac stent patients to receive personalized antiplatelet therapy

Clinical trial comparing Prasurgrel to Clopidogrel following percutaneous coronary intervention is ended early

Cangrelor provides effective maintenance of platelet inhibition without major bleeding for patients who require bypass surgery

Prasugrel, Ticagrelor Reduced Incidence of Stent Thrombosis

Delayed Stenting Optimizes Microvascular Perfusion in STEMI Patients

High Platelet Reactivity Predicts Poor Outcomes, Routine Testing Still Debated

Clopidogrel Reactions Treatable Without Stopping Antiplatelet Therapy

Increased Clopidogrel Fails to Overcome High Platelet Reactivity

ESC Congress 2011: Drugs, Devices Work Together

Halting Clopidogrel in First Year Following Acute MI Hazardous

GRAVITAS Analysis: Lower Cutpoint May Enhance Functional Platelet Testing

Women Have Less Neointimal Hyperplasia Than Men With ZES

Poor Association Between Stent Thrombosis, Platelet Function Tests

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content